Live News

The prognostic impact of pregnancy-associated melanoma on overall and melanoma-specific survival: A systematic review and meta-analysis

Critical Reviews In Oncology Hematology

0 0

First-line immunotherapy with or without PARP inhibitors in advanced ovarian cancer: A meta-analysis including bevacizumab use, molecular status, and PD-L1 expression

Critical Reviews In Oncology Hematology

0 0

PCSK9 in the liver metastatic niche: From cholesterol homeostasis to tumor microenvironment reprogramming

Critical Reviews In Oncology Hematology

0 0

Mitophagy in lymph node metastasis: Mechanisms, immune consequences and therapeutic opportunities

Critical Reviews In Oncology Hematology

0 0

Dendritic cell-driven immune rebalancing as a systemic regulator of tumor and neurodegenerative microenvironments

Critical Reviews In Oncology Hematology

0 0

Overcoming immunotherapy resistance in extensive-stage small cell lung cancer: Insights into mechanisms and therapeutic opportunities

Critical Reviews In Oncology Hematology

0 0

Harnessing myeloid plasticity in CAR macrophages for solid tumor immunotherapy

Critical Reviews In Oncology Hematology

0 0

Bile acids in the tumor immune microenvironment of hepatocellular carcinoma: Mechanisms of immunotherapy resistance and therapeutic opportunities

Critical Reviews In Oncology Hematology

0 0

Hybrid membrane nanosystems for cancer immunotherapy: Biomimetic design, immune activation, and translational potential

Critical Reviews In Oncology Hematology

0 0

Neoadjuvant immunotherapy in locally advanced head and neck squamous cell carcinoma: From oncologic outcomes to response-adaptive treatment de-escalation

Critical Reviews In Oncology Hematology

0 0

Immune checkpoint inhibitor resistance in non-small cell lung cancer: An updated view through the cancer-immunity cycle

Critical Reviews In Oncology Hematology

0 0

Macrophages in colorectal cancer: Origin, function and significance of targeted therapy

Critical Reviews In Oncology Hematology

0 0

Translational aspects of Desmoplastic small round cell tumor (DSRCT): An expert consensus paper from the OCTOPUS group

Critical Reviews In Oncology Hematology

0 0

Molecular understanding and clinical aspects of adoptive cellular immunotherapy in prostate cancer

Critical Reviews In Oncology Hematology

0 0

From bone alterations to tumours: Genetic drivers linking Paget’s disease of bone to cancer

Critical Reviews In Oncology Hematology

0 0

Title: Role of O6-methylguanine DNA methyltransferase status as predictive factor for alkylatin-based chemotherapy in advanced neuroendocrine tumors: State of the art

Critical Reviews In Oncology Hematology

0 0

Targeting KRAS G12C in non-small cell lung cancer: Breakthrough inhibitors and combination approaches

Critical Reviews In Oncology Hematology

0 0

Gut microbiome dysbiosis and cancer: A systematic review on the emerging role of probiotics in oncology

Critical Reviews In Oncology Hematology

0 0

Brain tumor susceptibility: From genetic predisposition syndromes to extended characterization of genomic determinants

Critical Reviews In Oncology Hematology

0 0

Research advances in dual-conversion therapy for hepatocellular carcinoma

Critical Reviews In Oncology Hematology

0 0

Myelodysplastic syndromes: Updates on Genomic Landscape, Molecular Subtypes, & Targeted Therapies

Advances in modern molecular and genomic testing have spurred tremendous progress in our understanding of MDS pathogenesis...

Current Hematologic Malignancy Reports

0 0

From MRD To Match: the Role of Allogeneic Hematopoietic Cell Transplant in Philadelphia-Negative B-ALL

Given the high risk of relapse for Philadelphia-negative (Ph-negative) B-cell acute lymphoblastic leukemia (ALL), allogene...

Current Hematologic Malignancy Reports

0 0

Targeting RUNX1 Germline Variants: Agents Under Investigation

Despite increased recognition of FPDMM and advancements in genetic technologies that have improved carrier identification ...

Current Hematologic Malignancy Reports

0 0

Impact of Germline DNA Repair Mutations on Clonal Hematopoiesis and Myeloid Neoplasm Development

Clonal hematopoiesis (CH) arises from the expansion of a single hematopoietic stem cell harboring somatic mutations that c...

Current Hematologic Malignancy Reports

0 0

Understanding Triple Negative Myeloproliferative Neoplasms and Identifying Molecular Drivers

Triple-negative (TN) myeloproliferative neoplasms (MPNs), defined by the absence of canonical driver JAK2, CALR and MPL mu...

Current Hematologic Malignancy Reports

0 0

Advances and Controversies in the Management of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Navigating First-Line Therapies

The goal of this review is to provide an updated synthesis of therapeutic advances and remaining controversies in the mana...

Current Hematologic Malignancy Reports

0 0

New Approaches for Measurable Residual Disease Assessment in Multiple Myeloma: Integrating NGS, Mass Spectrometry, and Next-Generation Flow Cytometry to Monitor Treatment Response

Measurable residual disease (MRD) has emerged as the strongest prognostic biomarker in multiple myeloma (MM), providing a ...

Current Hematologic Malignancy Reports

0 0

When Targeted Therapy Falls Short: Unraveling Resistance Mechanisms in Chronic Lymphocytic Leukemia

Targeted therapies have revolutionized the treatment of chronic lymphocytic leukemia (CLL), however the disease remains in...

Current Hematologic Malignancy Reports

0 0

Molecular Pathogenesis and Targeted Therapies for Myeloproliferative Hypereosinophilic Neoplasms

This review examines the rapidly evolving landscape of myeloproliferative hypereosinophilic syndromes (HES) and related ne...

Current Hematologic Malignancy Reports

0 0

Clonal Signatures of Telomere Biology Disorders

In inherited bone marrow failure syndromes (IBMFS), clonal hematopoiesis (CH) has been increasingly recognized as a molecu...

Current Hematologic Malignancy Reports

0 0

Categories

Channels

SCI Abstract